Sona Nanotech Inc (TSE:SONA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sona Nanotech Inc. announced promising results from its preclinical study using Targeted Hyperthermia Therapy to treat colorectal cancer, which showed enhanced response rates when combined with standard immunotherapy. The study revealed that tumors in mice were significantly reduced, with half of them eliminated, demonstrating the potential of the therapy to convert resistant cancers into responsive ones.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.